The clinical use of the neuromuscular blocking agent fazadinium was investigated in a survey of 500 patients. Rapid conditions fortracheal intubation followed by excellent relaxation and easy antagonism were obtained. It is suggested that these findings commend it as an alternative to suxamethonium. Tachycardia appeared to be the only disadvantage associated with its use.
The clinical use of the new non-depolarizing neuromuscular blocking agent fazadinium (Fazadon, Duncan Flockhart & Co. Ltd) has been investigated by a number of workers (Simpson et al., 1972; Arora et al., 1973; Coleman et al., 1973; Savege et al., 1973) . These initial studies involved varying degrees of complexity thus reducing the number of patients studied. Other investigators have compared specific properties of fazadinium with alternative compounds in controlled trials (Young, Clarke and Dundee, 1974; Hartley and Fidler, 1977) . Neither of these methods of investigation represent the routine clinical use of a product where patients are unselected and managed in all other aspects of anaesthesia as befits their individual need. Therefore, a survey of the general properties of fazadinium, with particular reference to ease of tracheal intubation and antagonism, was undertaken in a series of 500 patients who required myoneural blockade as part of the anaesthetic regimen.
PATIENTS AND METHODS
Fazadinium was given to 500 patients who presented for routine (84.0%) or emergency (16.0%) surgical, orthopaedic or gynaecological procedures and which necessitated neuromuscular block. The patients were studied consecutively except for a period when supplies of fazadinium were in short supply and it was reserved for those patients in whom special problems were anticipated.
The anaesthetic technique was chosen to meet the requirements of each patient following the practice of one anaesthetist (D. E. R.) who administered each anaesthetic. The dose of fazadinium for each patient was intended to be sufficient for tracheal intubation, D. E. ROWLANDS, F.F.A.R.C.S., Llandudno General Hospital, Llandudno, Gwynedd. K. FIDLER,* B.PHARM., M.P.S., Glaxo Research Limited, Greenford, Middlesex UB6 OHE.
•Present address: Clinical Pharmacology Unit, Abbott Laboratories Limited, 53A High Street, Esher, Surrey. increments being administered during longer operations. Intubation was attempted as soon as muscle relaxation appeared adequate. Residual blockade was antagonized with neostigmine preceded by atropine.
Details of the agents used, intubation, antagonism and side-effects were recorded for all patients. Intubation was assessed according to the classification of Lund and Stovner (1962) (table I) . The pulse was monitored by palpation or with a pulse monitor (M.I.E.) and the arterial pressure was measured by upper arm sphygmomanometry.
A list of possible side-effects relating to the respiratory and cardiovascular systems together with miscellaneous reactions was noted for each patient and recorded as: severe, mild, absent or not monitored. After the administration of neostigmine respiration was assessed clinically at 1-min intervals until it was considered adequate, and recorded as absent, poor, fair or adequate.
RESULTS
The sex and weight distributions of all patients are shown in table II. The "Classification of Physical Status" as denned by the American Society of Anesthesiologists (1963) was used as an index of morbidity and the disposition of this factor within various age groups is shown in table III.
Premedication
Three hundred and ninety-one patients (78.2%) received diazepam 10 mg (i.m. or orally) as the sole premedicant 15-420 min before induction. Fifty-one patients received other agents and combinations, such as pethidine, chlorpromazine and morphine, whilst 58 were unpremedicated. Atropine 0.6 mg was given with the induction agent in 51 patients in whom anaesthesia was maintained with halothane and 13 poor risk patients received droperidol and fentanyl over periods of 5-10 min whilst inhaling oxygen immediately before induction.
Induction and intubation
In 440 patients anaesthesia was induced with Althesin 65.9 ^litre kg-1 (SD 8.22) given over 30-45 s and in the remaining 60 patients with methohexitone 1.27 mg kg" 1 (SD 0.20) . Once the patient was asleep, fazadinium 0.67 mg kg" 1 (SD 0.13) was injected through the same needle. Of the first 100 patients, only seven needed more than fazadinium 45 mg for intubation and this was subsequently used as a maximum except in a further three patients.
The times and conditions of intubation are shown in Variations in premedication appeared to make no difference to the ease of intubation.
Maintenance
The majority of patients (431; 87.0%) were hyperventilated moderately with nitrous oxide 70% in oxygen using a Manley ventilator. Of these, 395 received droperidol 5 mg and fentanyl 0.1 mg during the first 15 min of the operation.
The amount of additional fazadinum required was in part dependent on the degree of hyperventilation, analgesia and type of surgery. In this series additional doses were required in 152 patients. The average time to the first additional dose was 35 min (SD 19.9) . In most cases 15 mg was sufficient. If conditions were not ideal for closure of the peritoneum fazadinium 7.5 mg was given. The maximum dose given was 165 mg given to a 70-kg patient for exploration of the common bile duct lasting 2 h 42 min.
The remaining 69 patients received one dose of fazadinium purely to aid tracheal intubation. Their lungs were ventilated manually with nitrous oxide and oxygen, until spontaneous respiration returned or the operation was completed. Halothane was given to 51 of these patients.
Antagonism
Antagonism was rarely difficult. Two hundred and five patients (41%) were showing signs of spontaneous respiratory activity before the administration of neostigmine. A dose of neostigmine 5 mg preceded by atropine 1.2 mg was given routinely (except for 12% who received 2.5 mg or less as they were of light weight or were already breathing satisfactorily).
In the manually ventilated group neostigmine was omitted in 27 patients in whom spontaneous breathing had been present for some time.
Six patients received additional neostigmine. Two (one who was moribund before operation, the other a poor risk patient with whom difficulty in antagonism had been experienced previously following gallamine) received this as part of the treatment of inadequate ventilation after operation. One patient received a relatively large dose of fazadinium (90 mg for an operation lasting approximately 30 min). Three patients received an additional dose of neostigmine which was considered unnecessary in retrospect. Of the remainder all except 21 were breathing satisfactorily within 6 min and all except one by 9 min after the neostigmine.
Complications
The frequency of complications is shown in table V. Respiratory. The symptoms appeared to be unrelated to the administration of fazadinium. Hiccup consisted of spasm of the diaphragm which cleared on altering the frequency of the ventilator. The severe case of bronchospasm occurred following straining at attempted intubation within 1 min of administration of the induction agent and fazadinium. A further 15 mg of fazadinium allowed intubation without additional complications. The two cases of mild bronchospasm occurred in patients with respiratory disease (bronchitis and asthma). The patient with bronchitis had dyspnoea and developed bronchospasm 15 min after induction and intubation. Tracheal toilet and an additional dose of fazadinium relieved the symptoms. A further 28 patients suffering from chronic bronchitis and three with asthma were managed successfully without complication.
Cardiovascular. Tachycardia was the most frequently observed complication and was classified as mild if the heart rate exceeded 100 beat min" 1 , or severe when greater than 140 beat min"
1 . Extrasystoles were observed in four patients during the course of the operation and one patient suffered coronary thrombosis 30 min after the start of anaesthesia, but such complications were not unexpected in a large series and were not thought to be a result of fazadinium.
It was not possible to separate the changes in arterial pressure from the effects of intubation, anaesthesia and surgery, but marked hypertension did not occur. In two patients severe hypertension was noted but was associated with the administration of metaraminol and patients exhibiting mild hypertension recovered to a normal pressure without treatment. Of the 13 patients who suffered marked hypotension, 10 were in poor physical condition (ASA grade 3 or less) and all were elderly (range 59-88 yr). Apart from one patient, all of these occurred within 15 min of the induction-intubation sequence.
Miscellaneous. Excessive sweating was seen in four patients during operation; two of these were patients aged 10 and 11 yr undergoing appendicectomy and one patient aged 14 yr was undergoing splenectomy. None of these had received droperidol or fentanyl during anaesthesia because of short operating times. The fourth patient underwent hysterectomy and sweated profusely during the last 30 min; a further dose of fentanyl may have prevented this. Involuntary movements in four patients might have been avoided by an additional dose of fazadinium given earlier.
The following events were noted, but these had little clinical significance and were not necessarily related to the use of fazadinium:
An allergic rash was seen on one leg of a patient the evening after the operation and on one arm (site of administration of most of the agents used) on the following morning. Another two patients had redness of the skin on the chest and neck for a short period during the operations. The surgeons involved commented adversely on only two occasions; one paient appeared to have greater gut distension than expected and another bled a little more than usual. Recovery of consciousness was delayed in one poorrisk patient. Fazadinium was not considered to be responsible as this had also occurred during a previous anaesthetic using a different muscle relaxant.
DISCUSSION
As most of the published work on intubating conditions after fazadinium was undertaken on patients in whom anaesthesia was induced with a barbiturate (Arora et al., 1973; Coleman et al., 1973; Young, Clarke and Dundee, 1974; Hartley and Fidler, 1977) , 60 patients in this study received methohexitone.
Intubation
The dose of fazadinium necessary for rapid and atraumatic intubation depends, as with similar agents, not only on the patient's anatomy and response to the drug but also on the skill and techniques of the individual anaesthetist. The dose recommended in previous publications has varied from as little as 0.4 mg kg-1 (Schuh, 1975 ) to 1.5 mg kg" 1 (Coleman et al., 1973) . In this series no difficulty was experienced when speedy intubation was required, provided a dose near to 0.75 mg kg -1 was chosen. Of the 14 patients in whom intubation was impossible at the first attempt, seven were difficult for anatomical reasons, four had received small doses, one had a slow blood circulation time and one appeared resistant to fazadinium (a patient weighing 50 kg and requiring 52.5 mg% fazadinium for an appedicectomy lasting less than 30 min).
Although both animal (Child et al., 1971) and clinical (Clarke, Dundee and Carson, 1972; Healy, Birmingham and Chatterjee, 1972 ) studies have indicated that Althesin has no inherent neuromuscular blocking properties, it has been suggested that there is local relaxation of the upper airway (Tomlin, 1972) . The results of this survey cannot be used for statistical support because of the lack of randomization, but our clinical impression certainly corroborates the implication, as does the frequency of 85% excellent or satisfactory intubations after fazadinium with Althesin compared with only 67% following methohexitone.
Maintenance and antagonism
Maintenance of myoneural block presented no problems. Antagonism was consistently easy, even when additional fazadinium had been administered during suturing of the peritoneum. No difficulties were experienced when fazadinium had been used solely for intubation in short procedures or in abdominal operations of short duration. Adequate respiration returned within a mean time of 11.4 min in 44 patients intended to breathe spontaneously with halothane (average dose of fazadinium = 0.57 mgkg-1 , SD0.1).
The dose of neostigmine used by us for antagonism (5 mg) could be regarded as unnecessarily large. However, for most of the trial a recovery room was not available and it had been found over the years that such a dose, rather than 2.5 mg, reduced considerably the number of urgent calls to the ward to deal with patients who were breathing inadequately after operation. Lack of recovery facilities was also a reason for the routine use of neostigmine and for the apparently unnecessary additional dose given to three patients.
Side-effects
The only consistent disadvantage of fazadinium was tachycardia.
CONCLUSIONS
This clinical appraisal of fazadinium indicates that it could be used as an alternative to suxamethonium for tracheal intubation, thereby avoiding the necessity of two myoneural blocking drugs, in longer operations, and the disadvantages of depolarizing agents. As fazadinium is antagonized easily it could be useful for outpatients who require endotracheal intubation.
ADDENDUM
Experience of the drug has now extended to more than 1000 patients. Of these, approximately 400 have received a slightly modified formulation containing 0.3% a-thioglycerol (added by the manufacturers for extending its shelf life). There have been no obvious clinical differences between the old and new formulations, as was found also by Buckley and Scott (1977) .
There was one possible case of allergy which developed 5-10 min following fazadinium preceded by Althesin. A female patient, who was suffering from scleroedema, developed generalized blotchy redness followed by peripheral cyanosis and oedema of the arms with absent radial pulses and no recordable arterial pressure. There was no bronchospasm. Satisfactory recovery ensued. Intradermal testing a few days after operation with histamine, Althesin and fazadinium produced no response, but the patient had been receiving chlorpheniramine following the reaction. Re-testing 10 days later produced flares with fazadinium and histamine. It is possible, therefore, that this reaction was a result of fazadinium, but interpretation of the test was difficult in the presence of scleroedema. 
SUMARIO
Se investigo la utilidad clinica del agente para bloqueo neuromuscular fazadinio en un estudio realizado con 500 pacientes. Se obtuvieron rSpidamente condiciones para intubation traqueal, seguidas por una excelente relajaci6n y facil reversion. Se sugiere que estos descubrimientos lo recomiendan como altemativa al suxametonio. La unica desventaja asociada con su empleo parece ser la taquicardia.
